Global LV-Based Cell and Gene Therapy Products Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
LV-based cell and gene therapy products refer to therapeutic products that utilize lentiviral vectors (LV) as a delivery system for introducing genetic material into target cells. Lentiviral vectors are commonly used in gene therapy to transfer genes into cells for the treatment of genetic disorders, cancer, and other diseases.
The global LV-Based Cell and Gene Therapy Products market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “LV-Based Cell and Gene Therapy Products Industry Forecast” looks at past sales and reviews total world LV-Based Cell and Gene Therapy Products sales in 2022, providing a comprehensive analysis by region and market sector of projected LV-Based Cell and Gene Therapy Products sales for 2023 through 2029. With LV-Based Cell and Gene Therapy Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world LV-Based Cell and Gene Therapy Products industry.
This Insight Report provides a comprehensive analysis of the global LV-Based Cell and Gene Therapy Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on LV-Based Cell and Gene Therapy Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global LV-Based Cell and Gene Therapy Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for LV-Based Cell and Gene Therapy Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global LV-Based Cell and Gene Therapy Products.
United States market for LV-Based Cell and Gene Therapy Products is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for LV-Based Cell and Gene Therapy Products is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for LV-Based Cell and Gene Therapy Products is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key LV-Based Cell and Gene Therapy Products players cover Novartis, Bluebird Bio, Thermo Fisher Scientific, Intas, BMS, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of LV-Based Cell and Gene Therapy Products market by product type, application, key players and key regions and countries.
Segmentation by Type:
LV-based cell and gene therapy products refer to therapeutic products that utilize lentiviral vectors (LV) as a delivery system for introducing genetic material into target cells. Lentiviral vectors are commonly used in gene therapy to transfer genes into cells for the treatment of genetic disorders, cancer, and other diseases.
The global LV-Based Cell and Gene Therapy Products market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “LV-Based Cell and Gene Therapy Products Industry Forecast” looks at past sales and reviews total world LV-Based Cell and Gene Therapy Products sales in 2022, providing a comprehensive analysis by region and market sector of projected LV-Based Cell and Gene Therapy Products sales for 2023 through 2029. With LV-Based Cell and Gene Therapy Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world LV-Based Cell and Gene Therapy Products industry.
This Insight Report provides a comprehensive analysis of the global LV-Based Cell and Gene Therapy Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on LV-Based Cell and Gene Therapy Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global LV-Based Cell and Gene Therapy Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for LV-Based Cell and Gene Therapy Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global LV-Based Cell and Gene Therapy Products.
United States market for LV-Based Cell and Gene Therapy Products is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for LV-Based Cell and Gene Therapy Products is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for LV-Based Cell and Gene Therapy Products is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key LV-Based Cell and Gene Therapy Products players cover Novartis, Bluebird Bio, Thermo Fisher Scientific, Intas, BMS, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of LV-Based Cell and Gene Therapy Products market by product type, application, key players and key regions and countries.
Segmentation by Type:
- CAR-T Therapy
- Autologous CD34+ Cell Gene Therapy
- Hospital
- Diagnostic and Testing Laboratories
- Academic and Research Organizations
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CAR-T Therapy
- Autologous CD34+ Cell Gene Therapy
- Hospital
- Diagnostic and Testing Laboratories
- Academic and Research Organizations
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Bluebird Bio
- Thermo Fisher Scientific
- Intas
- BMS
- Orchard Therapeutics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global LV-Based Cell and Gene Therapy Products Market Size 2019-2030
2.1.2 LV-Based Cell and Gene Therapy Products Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for LV-Based Cell and Gene Therapy Products by Country/Region, 2019, 2023 & 2030
2.2 LV-Based Cell and Gene Therapy Products Segment by Type
2.2.1 CAR-T Therapy
2.2.2 Autologous CD34+ Cell Gene Therapy
2.3 LV-Based Cell and Gene Therapy Products Market Size by Type
2.3.1 LV-Based Cell and Gene Therapy Products Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Type (2019-2024)
2.4 LV-Based Cell and Gene Therapy Products Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic and Testing Laboratories
2.4.3 Academic and Research Organizations
2.4.4 Others
2.5 LV-Based Cell and Gene Therapy Products Market Size by Application
2.5.1 LV-Based Cell and Gene Therapy Products Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Application (2019-2024)
3 LV-BASED CELL AND GENE THERAPY PRODUCTS MARKET SIZE BY PLAYER
3.1 LV-Based Cell and Gene Therapy Products Market Size Market Share by Player
3.1.1 Global LV-Based Cell and Gene Therapy Products Revenue by Player (2019-2024)
3.1.2 Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Player (2019-2024)
3.2 Global LV-Based Cell and Gene Therapy Products Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LV-BASED CELL AND GENE THERAPY PRODUCTS BY REGION
4.1 LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024)
4.2 Global LV-Based Cell and Gene Therapy Products Annual Revenue by Country/Region (2019-2024)
4.3 Americas LV-Based Cell and Gene Therapy Products Market Size Growth (2019-2024)
4.4 APAC LV-Based Cell and Gene Therapy Products Market Size Growth (2019-2024)
4.5 Europe LV-Based Cell and Gene Therapy Products Market Size Growth (2019-2024)
4.6 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024)
5.2 Americas LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024)
5.3 Americas LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024)
6.2 APAC LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024)
6.3 APAC LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024)
7.2 Europe LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024)
7.3 Europe LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa LV-Based Cell and Gene Therapy Products by Region (2019-2024)
8.2 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024)
8.3 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LV-BASED CELL AND GENE THERAPY PRODUCTS MARKET FORECAST
10.1 Global LV-Based Cell and Gene Therapy Products Forecast by Region (2025-2030)
10.1.1 Global LV-Based Cell and Gene Therapy Products Forecast by Region (2025-2030)
10.1.2 Americas LV-Based Cell and Gene Therapy Products Forecast
10.1.3 APAC LV-Based Cell and Gene Therapy Products Forecast
10.1.4 Europe LV-Based Cell and Gene Therapy Products Forecast
10.1.5 Middle East & Africa LV-Based Cell and Gene Therapy Products Forecast
10.2 Americas LV-Based Cell and Gene Therapy Products Forecast by Country (2025-2030)
10.2.1 United States Market LV-Based Cell and Gene Therapy Products Forecast
10.2.2 Canada Market LV-Based Cell and Gene Therapy Products Forecast
10.2.3 Mexico Market LV-Based Cell and Gene Therapy Products Forecast
10.2.4 Brazil Market LV-Based Cell and Gene Therapy Products Forecast
10.3 APAC LV-Based Cell and Gene Therapy Products Forecast by Region (2025-2030)
10.3.1 China LV-Based Cell and Gene Therapy Products Market Forecast
10.3.2 Japan Market LV-Based Cell and Gene Therapy Products Forecast
10.3.3 Korea Market LV-Based Cell and Gene Therapy Products Forecast
10.3.4 Southeast Asia Market LV-Based Cell and Gene Therapy Products Forecast
10.3.5 India Market LV-Based Cell and Gene Therapy Products Forecast
10.3.6 Australia Market LV-Based Cell and Gene Therapy Products Forecast
10.4 Europe LV-Based Cell and Gene Therapy Products Forecast by Country (2025-2030)
10.4.1 Germany Market LV-Based Cell and Gene Therapy Products Forecast
10.4.2 France Market LV-Based Cell and Gene Therapy Products Forecast
10.4.3 UK Market LV-Based Cell and Gene Therapy Products Forecast
10.4.4 Italy Market LV-Based Cell and Gene Therapy Products Forecast
10.4.5 Russia Market LV-Based Cell and Gene Therapy Products Forecast
10.5 Middle East & Africa LV-Based Cell and Gene Therapy Products Forecast by Region (2025-2030)
10.5.1 Egypt Market LV-Based Cell and Gene Therapy Products Forecast
10.5.2 South Africa Market LV-Based Cell and Gene Therapy Products Forecast
10.5.3 Israel Market LV-Based Cell and Gene Therapy Products Forecast
10.5.4 Turkey Market LV-Based Cell and Gene Therapy Products Forecast
10.6 Global LV-Based Cell and Gene Therapy Products Forecast by Type (2025-2030)
10.7 Global LV-Based Cell and Gene Therapy Products Forecast by Application (2025-2030)
10.7.1 GCC Countries Market LV-Based Cell and Gene Therapy Products Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis LV-Based Cell and Gene Therapy Products Product Offered
11.1.3 Novartis LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Bluebird Bio
11.2.1 Bluebird Bio Company Information
11.2.2 Bluebird Bio LV-Based Cell and Gene Therapy Products Product Offered
11.2.3 Bluebird Bio LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bluebird Bio Main Business Overview
11.2.5 Bluebird Bio Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Product Offered
11.3.3 Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Intas
11.4.1 Intas Company Information
11.4.2 Intas LV-Based Cell and Gene Therapy Products Product Offered
11.4.3 Intas LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Intas Main Business Overview
11.4.5 Intas Latest Developments
11.5 BMS
11.5.1 BMS Company Information
11.5.2 BMS LV-Based Cell and Gene Therapy Products Product Offered
11.5.3 BMS LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BMS Main Business Overview
11.5.5 BMS Latest Developments
11.6 Orchard Therapeutics
11.6.1 Orchard Therapeutics Company Information
11.6.2 Orchard Therapeutics LV-Based Cell and Gene Therapy Products Product Offered
11.6.3 Orchard Therapeutics LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Orchard Therapeutics Main Business Overview
11.6.5 Orchard Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global LV-Based Cell and Gene Therapy Products Market Size 2019-2030
2.1.2 LV-Based Cell and Gene Therapy Products Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for LV-Based Cell and Gene Therapy Products by Country/Region, 2019, 2023 & 2030
2.2 LV-Based Cell and Gene Therapy Products Segment by Type
2.2.1 CAR-T Therapy
2.2.2 Autologous CD34+ Cell Gene Therapy
2.3 LV-Based Cell and Gene Therapy Products Market Size by Type
2.3.1 LV-Based Cell and Gene Therapy Products Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Type (2019-2024)
2.4 LV-Based Cell and Gene Therapy Products Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic and Testing Laboratories
2.4.3 Academic and Research Organizations
2.4.4 Others
2.5 LV-Based Cell and Gene Therapy Products Market Size by Application
2.5.1 LV-Based Cell and Gene Therapy Products Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Application (2019-2024)
3 LV-BASED CELL AND GENE THERAPY PRODUCTS MARKET SIZE BY PLAYER
3.1 LV-Based Cell and Gene Therapy Products Market Size Market Share by Player
3.1.1 Global LV-Based Cell and Gene Therapy Products Revenue by Player (2019-2024)
3.1.2 Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Player (2019-2024)
3.2 Global LV-Based Cell and Gene Therapy Products Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LV-BASED CELL AND GENE THERAPY PRODUCTS BY REGION
4.1 LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024)
4.2 Global LV-Based Cell and Gene Therapy Products Annual Revenue by Country/Region (2019-2024)
4.3 Americas LV-Based Cell and Gene Therapy Products Market Size Growth (2019-2024)
4.4 APAC LV-Based Cell and Gene Therapy Products Market Size Growth (2019-2024)
4.5 Europe LV-Based Cell and Gene Therapy Products Market Size Growth (2019-2024)
4.6 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024)
5.2 Americas LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024)
5.3 Americas LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024)
6.2 APAC LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024)
6.3 APAC LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024)
7.2 Europe LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024)
7.3 Europe LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa LV-Based Cell and Gene Therapy Products by Region (2019-2024)
8.2 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024)
8.3 Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LV-BASED CELL AND GENE THERAPY PRODUCTS MARKET FORECAST
10.1 Global LV-Based Cell and Gene Therapy Products Forecast by Region (2025-2030)
10.1.1 Global LV-Based Cell and Gene Therapy Products Forecast by Region (2025-2030)
10.1.2 Americas LV-Based Cell and Gene Therapy Products Forecast
10.1.3 APAC LV-Based Cell and Gene Therapy Products Forecast
10.1.4 Europe LV-Based Cell and Gene Therapy Products Forecast
10.1.5 Middle East & Africa LV-Based Cell and Gene Therapy Products Forecast
10.2 Americas LV-Based Cell and Gene Therapy Products Forecast by Country (2025-2030)
10.2.1 United States Market LV-Based Cell and Gene Therapy Products Forecast
10.2.2 Canada Market LV-Based Cell and Gene Therapy Products Forecast
10.2.3 Mexico Market LV-Based Cell and Gene Therapy Products Forecast
10.2.4 Brazil Market LV-Based Cell and Gene Therapy Products Forecast
10.3 APAC LV-Based Cell and Gene Therapy Products Forecast by Region (2025-2030)
10.3.1 China LV-Based Cell and Gene Therapy Products Market Forecast
10.3.2 Japan Market LV-Based Cell and Gene Therapy Products Forecast
10.3.3 Korea Market LV-Based Cell and Gene Therapy Products Forecast
10.3.4 Southeast Asia Market LV-Based Cell and Gene Therapy Products Forecast
10.3.5 India Market LV-Based Cell and Gene Therapy Products Forecast
10.3.6 Australia Market LV-Based Cell and Gene Therapy Products Forecast
10.4 Europe LV-Based Cell and Gene Therapy Products Forecast by Country (2025-2030)
10.4.1 Germany Market LV-Based Cell and Gene Therapy Products Forecast
10.4.2 France Market LV-Based Cell and Gene Therapy Products Forecast
10.4.3 UK Market LV-Based Cell and Gene Therapy Products Forecast
10.4.4 Italy Market LV-Based Cell and Gene Therapy Products Forecast
10.4.5 Russia Market LV-Based Cell and Gene Therapy Products Forecast
10.5 Middle East & Africa LV-Based Cell and Gene Therapy Products Forecast by Region (2025-2030)
10.5.1 Egypt Market LV-Based Cell and Gene Therapy Products Forecast
10.5.2 South Africa Market LV-Based Cell and Gene Therapy Products Forecast
10.5.3 Israel Market LV-Based Cell and Gene Therapy Products Forecast
10.5.4 Turkey Market LV-Based Cell and Gene Therapy Products Forecast
10.6 Global LV-Based Cell and Gene Therapy Products Forecast by Type (2025-2030)
10.7 Global LV-Based Cell and Gene Therapy Products Forecast by Application (2025-2030)
10.7.1 GCC Countries Market LV-Based Cell and Gene Therapy Products Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis LV-Based Cell and Gene Therapy Products Product Offered
11.1.3 Novartis LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Bluebird Bio
11.2.1 Bluebird Bio Company Information
11.2.2 Bluebird Bio LV-Based Cell and Gene Therapy Products Product Offered
11.2.3 Bluebird Bio LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bluebird Bio Main Business Overview
11.2.5 Bluebird Bio Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Product Offered
11.3.3 Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Intas
11.4.1 Intas Company Information
11.4.2 Intas LV-Based Cell and Gene Therapy Products Product Offered
11.4.3 Intas LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Intas Main Business Overview
11.4.5 Intas Latest Developments
11.5 BMS
11.5.1 BMS Company Information
11.5.2 BMS LV-Based Cell and Gene Therapy Products Product Offered
11.5.3 BMS LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BMS Main Business Overview
11.5.5 BMS Latest Developments
11.6 Orchard Therapeutics
11.6.1 Orchard Therapeutics Company Information
11.6.2 Orchard Therapeutics LV-Based Cell and Gene Therapy Products Product Offered
11.6.3 Orchard Therapeutics LV-Based Cell and Gene Therapy Products Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Orchard Therapeutics Main Business Overview
11.6.5 Orchard Therapeutics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. LV-Based Cell and Gene Therapy Products Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. LV-Based Cell and Gene Therapy Products Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CAR-T Therapy
Table 4. Major Players of Autologous CD34+ Cell Gene Therapy
Table 5. LV-Based Cell and Gene Therapy Products Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024) & ($ millions)
Table 7. Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Type (2019-2024)
Table 8. LV-Based Cell and Gene Therapy Products Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024) & ($ millions)
Table 10. Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Application (2019-2024)
Table 11. Global LV-Based Cell and Gene Therapy Products Revenue by Player (2019-2024) & ($ millions)
Table 12. Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Player (2019-2024)
Table 13. LV-Based Cell and Gene Therapy Products Key Players Head office and Products Offered
Table 14. LV-Based Cell and Gene Therapy Products Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024) & ($ millions)
Table 18. Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Region (2019-2024)
Table 19. Global LV-Based Cell and Gene Therapy Products Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas LV-Based Cell and Gene Therapy Products Market Size Market Share by Country (2019-2024)
Table 23. Americas LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas LV-Based Cell and Gene Therapy Products Market Size Market Share by Type (2019-2024)
Table 25. Americas LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas LV-Based Cell and Gene Therapy Products Market Size Market Share by Application (2019-2024)
Table 27. APAC LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC LV-Based Cell and Gene Therapy Products Market Size Market Share by Region (2019-2024)
Table 29. APAC LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe LV-Based Cell and Gene Therapy Products Market Size Market Share by Country (2019-2024)
Table 33. Europe LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of LV-Based Cell and Gene Therapy Products
Table 39. Key Market Challenges & Risks of LV-Based Cell and Gene Therapy Products
Table 40. Key Industry Trends of LV-Based Cell and Gene Therapy Products
Table 41. Global LV-Based Cell and Gene Therapy Products Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global LV-Based Cell and Gene Therapy Products Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global LV-Based Cell and Gene Therapy Products Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global LV-Based Cell and Gene Therapy Products Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. Novartis Details, Company Type, LV-Based Cell and Gene Therapy Products Area Served and Its Competitors
Table 46. Novartis LV-Based Cell and Gene Therapy Products Product Offered
Table 47. Novartis LV-Based Cell and Gene Therapy Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. Novartis Main Business
Table 49. Novartis Latest Developments
Table 50. Bluebird Bio Details, Company Type, LV-Based Cell and Gene Therapy Products Area Served and Its Competitors
Table 51. Bluebird Bio LV-Based Cell and Gene Therapy Products Product Offered
Table 52. Bluebird Bio LV-Based Cell and Gene Therapy Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Bluebird Bio Main Business
Table 54. Bluebird Bio Latest Developments
Table 55. Thermo Fisher Scientific Details, Company Type, LV-Based Cell and Gene Therapy Products Area Served and Its Competitors
Table 56. Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Product Offered
Table 57. Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Thermo Fisher Scientific Main Business
Table 59. Thermo Fisher Scientific Latest Developments
Table 60. Intas Details, Company Type, LV-Based Cell and Gene Therapy Products Area Served and Its Competitors
Table 61. Intas LV-Based Cell and Gene Therapy Products Product Offered
Table 62. Intas LV-Based Cell and Gene Therapy Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Intas Main Business
Table 64. Intas Latest Developments
Table 65. BMS Details, Company Type, LV-Based Cell and Gene Therapy Products Area Served and Its Competitors
Table 66. BMS LV-Based Cell and Gene Therapy Products Product Offered
Table 67. BMS LV-Based Cell and Gene Therapy Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. BMS Main Business
Table 69. BMS Latest Developments
Table 70. Orchard Therapeutics Details, Company Type, LV-Based Cell and Gene Therapy Products Area Served and Its Competitors
Table 71. Orchard Therapeutics LV-Based Cell and Gene Therapy Products Product Offered
Table 72. Orchard Therapeutics LV-Based Cell and Gene Therapy Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Orchard Therapeutics Main Business
Table 74. Orchard Therapeutics Latest Developments
Table 1. LV-Based Cell and Gene Therapy Products Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. LV-Based Cell and Gene Therapy Products Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CAR-T Therapy
Table 4. Major Players of Autologous CD34+ Cell Gene Therapy
Table 5. LV-Based Cell and Gene Therapy Products Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024) & ($ millions)
Table 7. Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Type (2019-2024)
Table 8. LV-Based Cell and Gene Therapy Products Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024) & ($ millions)
Table 10. Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Application (2019-2024)
Table 11. Global LV-Based Cell and Gene Therapy Products Revenue by Player (2019-2024) & ($ millions)
Table 12. Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Player (2019-2024)
Table 13. LV-Based Cell and Gene Therapy Products Key Players Head office and Products Offered
Table 14. LV-Based Cell and Gene Therapy Products Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024) & ($ millions)
Table 18. Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Region (2019-2024)
Table 19. Global LV-Based Cell and Gene Therapy Products Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas LV-Based Cell and Gene Therapy Products Market Size Market Share by Country (2019-2024)
Table 23. Americas LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas LV-Based Cell and Gene Therapy Products Market Size Market Share by Type (2019-2024)
Table 25. Americas LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas LV-Based Cell and Gene Therapy Products Market Size Market Share by Application (2019-2024)
Table 27. APAC LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC LV-Based Cell and Gene Therapy Products Market Size Market Share by Region (2019-2024)
Table 29. APAC LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe LV-Based Cell and Gene Therapy Products Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe LV-Based Cell and Gene Therapy Products Market Size Market Share by Country (2019-2024)
Table 33. Europe LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of LV-Based Cell and Gene Therapy Products
Table 39. Key Market Challenges & Risks of LV-Based Cell and Gene Therapy Products
Table 40. Key Industry Trends of LV-Based Cell and Gene Therapy Products
Table 41. Global LV-Based Cell and Gene Therapy Products Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global LV-Based Cell and Gene Therapy Products Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global LV-Based Cell and Gene Therapy Products Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global LV-Based Cell and Gene Therapy Products Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. Novartis Details, Company Type, LV-Based Cell and Gene Therapy Products Area Served and Its Competitors
Table 46. Novartis LV-Based Cell and Gene Therapy Products Product Offered
Table 47. Novartis LV-Based Cell and Gene Therapy Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. Novartis Main Business
Table 49. Novartis Latest Developments
Table 50. Bluebird Bio Details, Company Type, LV-Based Cell and Gene Therapy Products Area Served and Its Competitors
Table 51. Bluebird Bio LV-Based Cell and Gene Therapy Products Product Offered
Table 52. Bluebird Bio LV-Based Cell and Gene Therapy Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Bluebird Bio Main Business
Table 54. Bluebird Bio Latest Developments
Table 55. Thermo Fisher Scientific Details, Company Type, LV-Based Cell and Gene Therapy Products Area Served and Its Competitors
Table 56. Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Product Offered
Table 57. Thermo Fisher Scientific LV-Based Cell and Gene Therapy Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Thermo Fisher Scientific Main Business
Table 59. Thermo Fisher Scientific Latest Developments
Table 60. Intas Details, Company Type, LV-Based Cell and Gene Therapy Products Area Served and Its Competitors
Table 61. Intas LV-Based Cell and Gene Therapy Products Product Offered
Table 62. Intas LV-Based Cell and Gene Therapy Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Intas Main Business
Table 64. Intas Latest Developments
Table 65. BMS Details, Company Type, LV-Based Cell and Gene Therapy Products Area Served and Its Competitors
Table 66. BMS LV-Based Cell and Gene Therapy Products Product Offered
Table 67. BMS LV-Based Cell and Gene Therapy Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. BMS Main Business
Table 69. BMS Latest Developments
Table 70. Orchard Therapeutics Details, Company Type, LV-Based Cell and Gene Therapy Products Area Served and Its Competitors
Table 71. Orchard Therapeutics LV-Based Cell and Gene Therapy Products Product Offered
Table 72. Orchard Therapeutics LV-Based Cell and Gene Therapy Products Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Orchard Therapeutics Main Business
Table 74. Orchard Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. LV-Based Cell and Gene Therapy Products Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global LV-Based Cell and Gene Therapy Products Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. LV-Based Cell and Gene Therapy Products Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. LV-Based Cell and Gene Therapy Products Sales Market Share by Country/Region (2023)
Figure 8. LV-Based Cell and Gene Therapy Products Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Type in 2023
Figure 10. LV-Based Cell and Gene Therapy Products in Hospital
Figure 11. Global LV-Based Cell and Gene Therapy Products Market: Hospital (2019-2024) & ($ millions)
Figure 12. LV-Based Cell and Gene Therapy Products in Diagnostic and Testing Laboratories
Figure 13. Global LV-Based Cell and Gene Therapy Products Market: Diagnostic and Testing Laboratories (2019-2024) & ($ millions)
Figure 14. LV-Based Cell and Gene Therapy Products in Academic and Research Organizations
Figure 15. Global LV-Based Cell and Gene Therapy Products Market: Academic and Research Organizations (2019-2024) & ($ millions)
Figure 16. LV-Based Cell and Gene Therapy Products in Others
Figure 17. Global LV-Based Cell and Gene Therapy Products Market: Others (2019-2024) & ($ millions)
Figure 18. Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Application in 2023
Figure 19. Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Player in 2023
Figure 20. Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Region (2019-2024)
Figure 21. Americas LV-Based Cell and Gene Therapy Products Market Size 2019-2024 ($ millions)
Figure 22. APAC LV-Based Cell and Gene Therapy Products Market Size 2019-2024 ($ millions)
Figure 23. Europe LV-Based Cell and Gene Therapy Products Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size 2019-2024 ($ millions)
Figure 25. Americas LV-Based Cell and Gene Therapy Products Value Market Share by Country in 2023
Figure 26. United States LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC LV-Based Cell and Gene Therapy Products Market Size Market Share by Region in 2023
Figure 31. APAC LV-Based Cell and Gene Therapy Products Market Size Market Share by Type (2019-2024)
Figure 32. APAC LV-Based Cell and Gene Therapy Products Market Size Market Share by Application (2019-2024)
Figure 33. China LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 37. India LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe LV-Based Cell and Gene Therapy Products Market Size Market Share by Country in 2023
Figure 40. Europe LV-Based Cell and Gene Therapy Products Market Size Market Share by Type (2019-2024)
Figure 41. Europe LV-Based Cell and Gene Therapy Products Market Size Market Share by Application (2019-2024)
Figure 42. Germany LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 43. France LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 44. UK LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size Market Share by Application (2019-2024)
Figure 50. Egypt LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 56. APAC LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 57. Europe LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 59. United States LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 60. Canada LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 61. Mexico LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 62. Brazil LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 63. China LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 64. Japan LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 65. Korea LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 67. India LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 68. Australia LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 69. Germany LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 70. France LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 71. UK LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 72. Italy LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 73. Russia LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 74. Egypt LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 75. South Africa LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 76. Israel LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 77. Turkey LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 79. Global LV-Based Cell and Gene Therapy Products Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global LV-Based Cell and Gene Therapy Products Market Size Market Share Forecast by Application (2025-2030)
Figure 1. LV-Based Cell and Gene Therapy Products Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global LV-Based Cell and Gene Therapy Products Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. LV-Based Cell and Gene Therapy Products Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. LV-Based Cell and Gene Therapy Products Sales Market Share by Country/Region (2023)
Figure 8. LV-Based Cell and Gene Therapy Products Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Type in 2023
Figure 10. LV-Based Cell and Gene Therapy Products in Hospital
Figure 11. Global LV-Based Cell and Gene Therapy Products Market: Hospital (2019-2024) & ($ millions)
Figure 12. LV-Based Cell and Gene Therapy Products in Diagnostic and Testing Laboratories
Figure 13. Global LV-Based Cell and Gene Therapy Products Market: Diagnostic and Testing Laboratories (2019-2024) & ($ millions)
Figure 14. LV-Based Cell and Gene Therapy Products in Academic and Research Organizations
Figure 15. Global LV-Based Cell and Gene Therapy Products Market: Academic and Research Organizations (2019-2024) & ($ millions)
Figure 16. LV-Based Cell and Gene Therapy Products in Others
Figure 17. Global LV-Based Cell and Gene Therapy Products Market: Others (2019-2024) & ($ millions)
Figure 18. Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Application in 2023
Figure 19. Global LV-Based Cell and Gene Therapy Products Revenue Market Share by Player in 2023
Figure 20. Global LV-Based Cell and Gene Therapy Products Market Size Market Share by Region (2019-2024)
Figure 21. Americas LV-Based Cell and Gene Therapy Products Market Size 2019-2024 ($ millions)
Figure 22. APAC LV-Based Cell and Gene Therapy Products Market Size 2019-2024 ($ millions)
Figure 23. Europe LV-Based Cell and Gene Therapy Products Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size 2019-2024 ($ millions)
Figure 25. Americas LV-Based Cell and Gene Therapy Products Value Market Share by Country in 2023
Figure 26. United States LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC LV-Based Cell and Gene Therapy Products Market Size Market Share by Region in 2023
Figure 31. APAC LV-Based Cell and Gene Therapy Products Market Size Market Share by Type (2019-2024)
Figure 32. APAC LV-Based Cell and Gene Therapy Products Market Size Market Share by Application (2019-2024)
Figure 33. China LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 37. India LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe LV-Based Cell and Gene Therapy Products Market Size Market Share by Country in 2023
Figure 40. Europe LV-Based Cell and Gene Therapy Products Market Size Market Share by Type (2019-2024)
Figure 41. Europe LV-Based Cell and Gene Therapy Products Market Size Market Share by Application (2019-2024)
Figure 42. Germany LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 43. France LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 44. UK LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size Market Share by Application (2019-2024)
Figure 50. Egypt LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries LV-Based Cell and Gene Therapy Products Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 56. APAC LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 57. Europe LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 59. United States LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 60. Canada LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 61. Mexico LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 62. Brazil LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 63. China LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 64. Japan LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 65. Korea LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 67. India LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 68. Australia LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 69. Germany LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 70. France LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 71. UK LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 72. Italy LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 73. Russia LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 74. Egypt LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 75. South Africa LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 76. Israel LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 77. Turkey LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries LV-Based Cell and Gene Therapy Products Market Size 2025-2030 ($ millions)
Figure 79. Global LV-Based Cell and Gene Therapy Products Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global LV-Based Cell and Gene Therapy Products Market Size Market Share Forecast by Application (2025-2030)
